semaglutide end date Full article: Effects of on one-year medical costs among patients with obesity or overweight in US real world setting Novo Nordisk patent expiry opens

We don't

What they found was cost dominates treatment decisions: 68% said cost influenced their decision to start or continue treatment 44% said the medication cost more than they expected Cost surpassed side effects as the #1 reason people stopped taking GLP-1s A breakdown of the financial burden: 24% pay more than $250 per prescription fill Nearly 8% pay $500 or more per fill 24% said insurance didn't cover any cost Weight management patients were nearly twice as likely to pay $250+ vs diabetes patients --- Here's what patients are thinking: Nearly 40% ended up using discount programs or manufacturer coupons 60% know someone who wants GLP-1s but can't afford them 83% believe Americans turn to DTC programs because traditional healthcare is too expensive Patients still prioritize safety: 60% are aware of safety risks with non-FDA-approved GLP-1s--this one surprised me

Discover why it happens and the best treatments to firm skin after weight loss

Weight loss triggered by semaglutide often leads to improved sleep patterns, reduced sleep apnea symptoms, and better overall rest quality

Methods This is a post hoc analysis of data from clinical trials